Argenx SE
ARGX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001697862
No open-market purchases or sales by Argenx SE insiders were filed in the last 90 days; 510 institutions reported holding it in 13F filings for Q2 2026, worth $26.1B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Argenx SE as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 177
- −14 vs. Q1 2021
- Shares held
- 28.5M
- −85.6K (−0.3%) vs. Q1 2021
- Total value
- $8.57B
- +$725.0M (+9.2%) vs. Q1 2021
- New holders
- 23
- 73 more added
- Sold out
- 37
- 54 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 510 | $26.1B |
| Q1 2026 | 478 | $21.1B |
| Q4 2025 | 510 | $25.0B |
| Q3 2025 | 470 | $22.5B |
| Q2 2025 | 439 | $17.7B |
| Q1 2025 | 448 | $19.7B |
| Q4 2024 | 397 | $21.0B |
| Q3 2024 | 358 | $19.0B |
| Q2 2024 | 336 | $14.7B |
| Q1 2024 | 328 | $13.4B |
| Q4 2023 | 346 | $12.5B |
| Q3 2023 | 341 | $15.9B |
| Q2 2023 | 290 | $12.0B |
| Q1 2023 | 272 | $11.6B |
| Q4 2022 | 271 | $11.6B |
| Q3 2022 | 255 | $11.2B |
| Q2 2022 | 232 | $12.4B |
| Q1 2022 | 199 | $10.2B |
| Q4 2021 | 208 | $10.1B |
| Q3 2021 | 182 | $8.57B |
| Q2 2021 | 177 | $8.57B |
| Q1 2021 | 191 | $7.84B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Argenx SE; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wetherby Asset Management Inc | 0 | $0 | 0.00% | −859−100.0% | Sold out |
| Mercer Global Advisors Inc | 0 | $0 | 0.00% | −852−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −790−100.0% | Sold out |
| Veracity Capital LLC | 0 | $0 | 0.00% | −743−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −731−100.0% | Sold out |
| WealthShield Partners, LLC | 0 | $0 | 0.00% | −208−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −156−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −95−100.0% | Sold out |
| James Investment Research Inc | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −34,421−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |